Patheon (PTHN) Priced

Global provider of contract drug manufacturing and development services.

Health Care - Life Sciences Tools & Services

IPO Performance
Latest Trade $32.44 0.00 (0.0%)
First Day Return 19.0%
Return from IPO 54.5%
 
Patheon IPO News more
  • .
IPO Data
IPO File Date 06/08/2015
Offer Price $21.00
Price Range $19.00 - $22.00
Offer Shares (mm) 29.8
Deal Size ($mm) 625
 
IPO Data
IPO Date 07/20/2016
Offer Price $21.00
Price Range $19.00 - $22.00
Offer Shares (mm) 29.8
Deal Size ($mm) $625
 
Underwriters
more
Business Overview
Patheon is a leading global provider of outsourced pharmaceutical development and manufacturing services. We provide a comprehensive, integrated and highly customizable range of active pharmaceutical ingredient, or API, and finished drug product services to our customers, from formulation development to clinical and commercial-scale manufacturing, packaging, and life cycle management. Our services address both small molecule and large molecule biological drugs. We believe we are the only end-to-end integrated provider of such services, which, combined with our scientific and regulatory expertise and specialized capabilities, allows our customers to partner with a single outsourced provider to address their most complex development and manufacturing needs. We believe we have the broadest technological capabilities in our industry, across the full spectrum of development and manufacturing, to support our end-to-end integrated platform.
Patheon is a leading global provider of outsourced pharmaceutical development and manufacturing services. We provide a comprehensive, integrated and highly customizable range of active pharmaceutical ingredient, or API, and finished drug product services to our customers, from formulation development to clinical and commercial-scale manufacturing, packaging, and...
more
Company Data
Headquarters Amsterdam, , Netherlands
Founded 1974
Employees 8,800
Website www.patheon.com
 

Performance vs. IPO Index (IPOUSA)